VIA Pharmaceuticals (VIA Pharmaceuticals) EBIT : $-5.91 Mil (TTM As of Dec. 2010)

VIA Pharmaceuticals EBIT Chart

VIA Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
EBIT		Get a 7-Day Free Trial					-8.22	-18.53	-20.46	-13.25	-5.91

VIA Pharmaceuticals Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
EBIT	Get a 7-Day Free Trial															-2.81	-2.43	-1.39	-1.21	-0.89

Competitive Comparison of VIA Pharmaceuticals's EBIT

For the Biotechnology subindustry, VIA Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIA Pharmaceuticals's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIA Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where VIA Pharmaceuticals's EV-to-EBIT falls into.

VIA Pharmaceuticals EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VIA Pharmaceuticals  (GREY:VIAP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

VIA Pharmaceuticals's annualized ROC % for the quarter that ended in Dec. 2010 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2010) data.

2. Joel Greenblatt's definition of Return on Capital:

VIA Pharmaceuticals's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2010 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2010) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

VIA Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VIA Pharmaceuticals EBIT Related Terms

Thank you for viewing the detailed overview of VIA Pharmaceuticals's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

VIA Pharmaceuticals (VIA Pharmaceuticals) Business Description